The amount of consideration that the Company is eligible to receive in future periods for the milestone or milestones.

No definition available.

Name:	dyax_AgreementsToReceiveInDevelopmentAndSalesMilestonePayments
Namespace Prefix:	dyax_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of consideration the Company received or is contractually eligible to receive for upfront or milestone payments.

+ References

No definition available.

+ Details

Name:	dyax_CollaborativeArrangementUpfrontAndMilestonePayments
Namespace Prefix:	dyax_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

+ Details

Name:	us-gaap_DeferredRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name:	us-gaap_Revenues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	dyax_DifferentTypesOfCollaborationAgreementsAxis=dyax_OtherRelatedPartyTransactionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DeferredRevenueArrangementTypeAxis=us-gaap_UpFrontPaymentArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dyax_DifferentTypesOfCollaborationAgreementsAxis=dyax_NovellusPlanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

SIGNIFICANT TRANSACTIONS - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
Significant Transactions [Line Items]
Revenue	$ 24,729	$ 21,993	$ 71,520	$ 55,695
CVie Therapeutics
Significant Transactions [Line Items]
Collaboration arrangement receivable						$ 11,000
Revenue	34	$ 36	82	$ 69
Deferred revenue	640		640		$ 723
CVie Therapeutics \| Up-front Payment Arrangement
Significant Transactions [Line Items]
Collaboration arrangement payment						$ 1,000
Novellus Plan
Significant Transactions [Line Items]
Deferred revenue	$ 500		$ 500
Novellus Plan \| Up-front Payment Arrangement
Significant Transactions [Line Items]
Collaboration arrangement payment					500
Collaboration arrangement receivable					$ 5,200